top of page

Recent Quotes

My Watchlist

Indicators

Markets:

Overview

News

Currencies

International

Treasuries

Integra LifeSciences Holdings Corporation - Common Stock (NQ:IART)

13.05 -0.53 (-3.90%)

Streaming Delayed Price Updated: 12:35 PM EST, Jan 12, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

Headline News about Integra LifeSciences Holdings Corporation - Common Stock

< Previous 1 2 3 4 5 6 7 Next >

3 Profitable Stocks with Questionable Fundamentals

January 06, 2026

Even if a company is profitable, it doesn’t always mean it’s a great investment. Some struggle to maintain growth, face looming threats, or fail to reinvest wisely, limiting their future potential.

Via StockStory

3 Reasons to Sell IART and 1 Stock to Buy Instead

January 04, 2026

Since July 2025, Integra LifeSciences has been in a holding pattern, posting a small loss of 4% while floating around $12.25. The stock also fell short of the S&P 500’s 9.9% gain during that period.

Via StockStory

Topics Stocks

3 of Wall Street’s Favorite Stocks with Open Questions

January 01, 2026

Wall Street is overwhelmingly bullish on the stocks in this article, with price targets suggesting significant upside potential. However, it’s worth remembering that analysts rarely issue sell ratings,...

Via StockStory

3 Volatile Stocks That Fall Short

December 14, 2025

Volatility cuts both ways - while it creates opportunities, it also increases risk, making sharp declines just as likely as big gains. This unpredictability can shake out even the most experienced...

Via StockStory

Earnings Scheduled For October 30, 2025 ↗

October 30, 2025

Via Benzinga

Integra LifeSciences, Evolent Health, Incyte, iRhythm, and Clover Health Stocks Trade Up, What You Need To Know

November 24, 2025

A number of stocks jumped in the afternoon session after a report revealed that the White House plans to pitch a two-year extension of Obamacare subsidies.

Via StockStory

Topics Economy

Align Technology, Tandem Diabetes, Integra LifeSciences, Lantheus, and Inspire Medical Systems Shares Skyrocket, What You Need To Know

November 21, 2025

A number of stocks jumped in the afternoon session after comments from a key Federal Reserve official bolstered hopes for an interest rate cut. New York Federal Reserve President John Williams stated...

Via StockStory

Topics Economy

1 Small-Cap Stock with Promising Prospects and 2 That Underwhelm

November 21, 2025

Investors looking for hidden gems should keep an eye on small-cap stocks because they’re frequently overlooked by Wall Street. Many opportunities exist in this part of the market, but it is also a...

Via StockStory

Surgical Equipment & Consumables - Specialty Stocks Q3 Recap: Benchmarking Integra LifeSciences (NASDAQ:IART)

November 16, 2025

Wrapping up Q3 earnings, we look at the numbers and key takeaways for the surgical equipment & consumables - specialty stocks, including Integra LifeSciences (NASDAQ:IART) and its peers.

Via StockStory

Topics Artificial Intelligence Economy

Integra LifeSciences (IART) Stock Trades Up, Here Is Why

November 13, 2025

Shares of medical device company Integra LifeSciences (NASDAQ:IART) jumped 1.7% in the afternoon session after the company received U.S. FDA 510(k) clearance for its CUSA Clarity Ultrasonic Surgical...

Via StockStory

3 of Wall Street’s Favorite Stocks We Keep Off Our Radar

November 09, 2025

Via StockStory

5 Must-Read Analyst Questions From Integra LifeSciences’s Q3 Earnings Call

November 06, 2025

Integra LifeSciences’ third quarter was marked by operational disruptions and underwhelming revenue growth, resulting in a significant negative market reaction. Management attributed the revenue...

Via StockStory

Topics Earnings Economy

Why Integra LifeSciences (IART) Shares Are Trading Lower Today

November 03, 2025

Shares of medical device company Integra LifeSciences (NASDAQ:IART) fell 5.7% in the afternoon session after the stock's negative momentum continued as the company reported weak third-quarter results...

Via StockStory

IART Q3 Deep Dive: Supply Chain Progress, Product Relaunches, and Margin Pressures Shape Outlook

October 31, 2025

Medical device company Integra LifeSciences (NASDAQ:IART) missed Wall Street’s revenue expectations in Q3 CY2025, but sales rose 5.6% year on year to $402.1 million. Next quarter’s revenue guidance of...

Via StockStory

Topics Economy World Trade

Why Integra LifeSciences (IART) Shares Are Sliding Today

October 30, 2025

Shares of medical device company Integra LifeSciences (NASDAQ:IART) fell 23% in the morning session after it reported third-quarter sales that missed expectations and provided a weak financial outlook....

Via StockStory

12 Health Care Stocks Moving In Thursday's Intraday Session ↗

October 30, 2025

Via Benzinga

The market is filled with gapping stocks in Thursday's session. ↗

October 30, 2025

Today's session on Thursday is marked by notable gaps in various stocks. Stay informed with the gap up and gap down stocks in today's session.

Via Chartmill

Integra LifeSciences (NASDAQ:IART) Posts Mixed Q3 2025 Results with EPS Beat and Revenue Miss ↗

October 30, 2025

Integra LifeSciences (IART) posted mixed Q3 2025 results, beating earnings estimates by 21.7% but missing revenue targets. The stock rose on the profit beat despite soft forward guidance.

Via Chartmill

Integra LifeSciences (NASDAQ:IART) Misses Q3 Sales Expectations

October 30, 2025

Via StockStory

Integra LifeSciences (IART) Q3 Earnings Report Preview: What To Look For

October 28, 2025

Medical device company Integra LifeSciences (NASDAQ:IART) will be reporting results this Thursday before market open. Here’s what to look for.

Via StockStory

Topics Artificial Intelligence

2 Stocks Under $50 for Long-Term Investors and 1 We Question

October 21, 2025

The $10-50 price range often includes mid-sized businesses with proven track records and plenty of growth runway ahead. They also usually carry less risk than penny stocks, though they’re not immune to...

Via StockStory

Sanara MedTech Inc. Navigates Market Downturn Amidst "Undervalued" Consensus and Strategic Shifts

October 17, 2025

Dallas, TX – October 17, 2025 – Sanara MedTech Inc. (NASDAQ: SMTI), a company focused on surgical and chronic wound care, finds itself in the spotlight today as a bottom market performer, with its...

Via MarketMinute

Organogenesis Holdings (ORGO) Battles Headwinds: Can This Regenerative Medicine Innovator Stage a Comeback?

October 17, 2025

Canton, MA – Organogenesis Holdings Inc. (NASDAQ: ORGO), a prominent player in the regenerative medicine sector, has recently endured a period of significant stock weakness, leaving investors...

Via MarketMinute

Topics Fraud

Why Integra LifeSciences (IART) Shares Are Trading Lower Today

October 15, 2025

Shares of medical device company Integra LifeSciences (NASDAQ:IART) fell in the afternoon session after Truist kept a Hold rating on the shares. The analyst mentioned in a research note that they...

Via StockStory

Topics Artificial Intelligence Economy Government

Integra LifeSciences, Inspire Medical Systems, Merit Medical Systems, Enovis, and CONMED Shares Are Falling, What You Need To Know

October 10, 2025

A number of stocks fell in the afternoon session after worries over worsening trade relations with China were triggered by critical comments from President Donald Trump.

Via StockStory

Topics Economy Government World Trade

3 Healthcare Stocks We Think Twice About

October 03, 2025

Personal health and wellness is one of the many secular tailwinds for healthcare companies. Despite the rosy long-term prospects, short-term headwinds such as COVID inventory destocking have caused the...

Via StockStory

Topics Stocks

Healthcare Sector Navigates Turbulent Waters as Drug Pricing Agreements Reshape Market Landscape

September 30, 2025

September 30, 2025 – The healthcare sector today finds itself at a pivotal juncture, experiencing a complex mix of optimism and apprehension. While a landmark drug-pricing agreement between...

Via MarketMinute

Topics Artificial Intelligence Economy Government

Masimo, Integra LifeSciences, CONMED, IQVIA, and Charles River Laboratories Shares Are Soaring, What You Need To Know

September 30, 2025

A number of stocks jumped in the afternoon session after reports revealed a potential drug-pricing agreement between the White House and the pharmaceutical industry. The Trump administration is...

Via StockStory

Topics Government World Trade

3 Reasons to Sell IART and 1 Stock to Buy Instead

September 30, 2025

Integra LifeSciences’s stock price has taken a beating over the past six months, shedding 39.3% of its value and falling to $13.34 per share. This might have investors contemplating their next move.

Via StockStory

Integra LifeSciences and LeMaitre Shares Are Falling, What You Need To Know

September 25, 2025

A number of stocks fell in the afternoon session after the U.S. Commerce Department initiated a national security investigation into medical equipment and devices, raising concerns about potential...

Via StockStory

Topics World Trade

< Previous 1 2 3 4 5 6 7 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

220 S. Main St.
Colville, WA 99114

Hours: Mon.-Fri., 8 a.m.-5 p.m.

509-684-4567
editor@statesmanexaminer.com

Site by Amber S. King – Creative Design

Home
About
Contact
Submissions

bottom of page